For the Inventor, By the Inventor

Enter assignee name

Hopkinton, MA, United States of America

Biomeasure Incorporated

USPTO Granted Patents = 52

CIPO Patents = 1

Forward Citations = 585

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Sun H Kim (27 out of 39 patents)

Jacques-Pierre Moreau (18 out of 43 patents)

David H Coy (10 out of 101 patents)

4. John E Taylor (10 out of 13 patents)

5. Arthur E Bogden (9 out of 9 patents)

6. Zheng Xin Dong (4 out of 70 patents)

7. Michael DeWitt Culler (2 out of 22 patents)

8. Michael Anthony Cawthorne (2 out of 11 patents)

9. Steven A Jackson (2 out of 12 patents)

10. Shalaby Wahba Shalaby (2 out of 201 patents)

11. Sylviane Moreau (2 out of 2 patents)

12. Francis Ignatious (2 out of 2 patents)

13. Barry A Morgan (1 out of 35 patents)

14. Matthew V Sennitt (1 out of 5 patents)

15. Yong-Ling Liu (1 out of 5 patents)

Core Competencies:

Somatostatin Analog

CCK Antagonist

Inhibitors of Fibrosis

Peptide Analogs

Hepatoma Treatment

Immunomodulators

Cyclic Peptide

Antiviral Compounds

Anti-arthritic Derivatives

Gastrointestinal Disorders

Tumor Growth Inhibition

Hyperlipidemia Treatment

52 patents: Sort by Forward Citations

1. 6268342 - Method of inhibiting fibrosis with a somatostatin agonist (2001-07-31),

2. 6180619 - Prenyl transferase inhibitors (2001-01-30),

3. 6150333 - Methods of using a somatostatin analogue (2000-11-21),

4. 6087337 - Method for treating benign and malignant proliferative skin disease (2000-07-11),

5. 6083915 - Method for treating liver cancer (2000-07-04),

6. 6004928 - Method of treating hyperlipidemia (1999-12-21),

7. 6001801 - Cyclic peptide analogs of somatostatin (1999-12-14),

8. 5969095 - Analogs of parathyroid hormone (1999-10-19),

9. 5968903 - Inhibition of H. pylori proliferation (1999-10-19),

10. 5877277 - Octapeptide bombesin analogs (1999-03-02),

11. 5821221 - Ionic molecular conjugates of N-acylated derivatives of (1998-10-13),

12. 5773455 - Inhibitors of prenyl transferases (1998-06-30),

13. 5767274 - Prenyl transferase inhibitors (1998-06-16),

14. 5767236 - Linear therapeutic peptides (1998-06-16),

15. 5763200 - Inhibition of amylin release (1998-06-09),

Biomeasure Incorporated, based in Hopkinton, MA, specializes in the development and manufacturing of therapeutic peptides. The company focuses on innovative solutions in the fields of somatostatin analogs, CCK antagonists, and inhibitors of fibrosis. Their research encompasses a range of applications, including hepatoma treatment and immunomodulation, leveraging cyclic peptides and antiviral compounds to address various medical challenges. Biomeasure is dedicated to advancing peptide-based therapies to improve patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Biomeasure Incorporated

52 Patents

#4 in Hopkinton, MA

#384 in Massachusetts

#6,757 in US

#13,537 in the World

Hopkinton, MA, United States of America

Biomeasure Incorporated

Forward Citations = 585

27 inventors:

Sun H Kim (27 out of 39 patents)

Jacques-Pierre Moreau (18 out of 43 patents)

David H Coy (10 out of 101 patents)

4. John E Taylor (10 out of 13 patents)

5. Arthur E Bogden (9 out of 9 patents)

Please report any incorrect information to [email protected]

Loading…